uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer
Show others and affiliations
2014 (English)In: Breast Cancer Research and Treatment, ISSN 0167-6806, E-ISSN 1573-7217, Vol. 143, no 1, 189-201 p.Article in journal (Refereed) Published
Abstract [en]

The aim of this study is to identify and validate copy number aberrations in early-stage primary breast tumors associated with bone or non-bone metastasis. Whole-genome molecular inversion probe arrays were used to evaluate copy number imbalances (CNIs) in breast tumors from 960 early-stage patients with information about site of metastasis. The CoxBoost algorithm was used to select metastasis site-related CNIs and to fit a Cox proportional hazards model. Gains at 1q41 and 1q42.12 and losses at 1p13.3, 8p22, and Xp11.3 were significantly associated with bone metastasis. Gains at 2p11.2, 3q21.3-22.2, 3q27.1, 10q23.1, and 14q13.2-3 and loss at 7q21.11 were associated with non-bone metastasis. To examine the joint effect of CNIs and clinical predictors, patients were stratified into three risk groups (low, intermediate, and high) based on the sum of predicted linear hazard ratios. For bone metastasis, the hazard (95 % confidence interval) for the low-risk group was 0.32 (0.11-0.92) compared to the intermediate-risk group and 2.99 (1.74-5.11) for the high-risk group. For non-bone metastasis, the hazard for the low-risk group was 0.34 (0.17-0.66) and 2.33 (1.59-3.43) for the high-risk group. The prognostic value of loss at 8p22 for bone metastasis and gains at 10q23.1 for non-bone metastasis, and gain at 11q13.5 for both bone and non-bone metastases were externally validated in 335 breast tumors pooled from four independent cohorts. Distinct CNIs are independently associated with bone and non-bone metastasis for early-stage breast cancer patients across cohorts. These data warrant consideration for tailoring surveillance and management of metastasis risk.

Place, publisher, year, edition, pages
2014. Vol. 143, no 1, 189-201 p.
National Category
Clinical Medicine
URN: urn:nbn:se:uu:diva-215824DOI: 10.1007/s10549-013-2796-3ISI: 000329295500019PubMedID: 24305980OAI: oai:DiVA.org:uu-215824DiVA: diva2:688587
Available from: 2014-01-17 Created: 2014-01-17 Last updated: 2014-11-18Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Wärnberg, Fredrik
By organisation
Endocrine Surgery
In the same journal
Breast Cancer Research and Treatment
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 280 hits
ReferencesLink to record
Permanent link

Direct link